Therapeutic Drug Monitoring Data
A Concise Guide
- 4th Edition - September 14, 2019
- Imprint: Academic Press
- Authors: Amitava Dasgupta, Matthew Krasowski
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 5 8 4 9 - 4
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 5 8 5 0 - 0
Therapeutic Drug Monitoring Data: A Concise Guide, Fourth Edition serves as a ready resource of information on commonly monitored drugs that will help readers make decisions… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteTherapeutic Drug Monitoring Data: A Concise Guide, Fourth Edition serves as a ready resource of information on commonly monitored drugs that will help readers make decisions relating to the monitoring and interpretation of results. It is an easy-to-read source of information on intended use, pharmacokinetics, therapeutic range, and toxic concentrations, as well as bioavailability, disposition, metabolism and the excretion of commonly monitored therapeutic drugs. This fully updated fourth edition includes sections on new anticonvulsants, anti-depressant and anti-HIV drugs, new drugs for advanced cancer treatment, and thoroughly updated chapters that address new pitfalls and problems in the lab.
- Serves as a ready resource of information for commonly monitored drugs
- Presents a useful, quick guide for those making decisions related to monitoring and interpretation of results
- Provides concise, easily digestible content for clinical laboratory scientists, toxicologists and clinicians
Pathologists, clinical chemists, and toxicologists; practicing clinicians, fellows and residents in pathology, internal medicine, emergency medicine and family practice
- Edition: 4
- Published: September 14, 2019
- No. of pages (Paperback): 382
- No. of pages (eBook): 382
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780128158494
- eBook ISBN: 9780128158500
AD
Amitava Dasgupta
Amitava Dasgupta received his Ph. D in chemistry from Stanford University and completed his fellowship training in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine at Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry. Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Medical Center and Director of Clinical Laboratories at the University of Kansas Hospital. Prior to this appointment he was a tenured Professor of Pathology and Laboratory Medicine at the University of Texas McGovern medical School from February 1998 to April 2022. He has 252 papers to his credit. He is in the editorial board of four journals including Therapeutic Drug Monitoring, Clinica Chimica Acta, Archives of Pathology and Laboratory Medicine, and Journal of Clinical Laboratory Analysis.
Affiliations and expertise
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United StatesMK
Matthew Krasowski
Matthew D. Krasowski, MD, PhD is a clinical pathologist and the Walter L. Bierring Professor of Clinical Education at the University of Iowa Carver College of Medicine. He currently serves as the Vice Chair of Clinical Pathology and Laboratory Services in the Department of Pathology at University of Iowa Hospitals and Clinics.
Affiliations and expertise
Department of Pathology and Laboratory Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USARead Therapeutic Drug Monitoring Data on ScienceDirect